.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Citi
McKesson
AstraZeneca
Johnson and Johnson
Daiichi Sankyo
UBS
Cipla
Moodys
Queensland Health

Generated: July 24, 2017

DrugPatentWatch Database Preview

Ergoloid mesylates - Generic Drug Details

« Back to Dashboard

What are the generic sources for ergoloid mesylates and what is the scope of ergoloid mesylates freedom to operate?

Ergoloid mesylates
is the generic ingredient in eight branded drugs marketed by Kv Pharm, Novartis, Watson Labs, Sun Pharm Inds, 3M, Vangard, Sandoz, Bristol Myers Squibb, Superpharm, Lederle, Ivax Pharms, and Mutual Pharm, and is included in thirty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for ergoloid mesylates. Two suppliers are listed for this compound.

Summary for Generic Name: ergoloid mesylates

Tradenames:8
Patents:1
Applicants:12
NDAs:34
Drug Master File Entries: see list4
Suppliers / Packagers: see list2
Clinical Trials: see list1
Therapeutic Class:Antidementia Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ergoloid mesylates at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kv Pharm
ERGOLOID MESYLATES
ergoloid mesylates
TABLET;SUBLINGUAL086265-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
ERGOLOID MESYLATES
ergoloid mesylates
TABLET;SUBLINGUAL087407-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
GERIMAL
ergoloid mesylates
TABLET;SUBLINGUAL086189-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
ALKERGOT
ergoloid mesylates
TABLET;SUBLINGUAL087417-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mutual Pharm
ERGOLOID MESYLATES
ergoloid mesylates
TABLET;ORAL088891-001Nov 1, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ergoloid mesylates

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
HYDERGINE LC
ergoloid mesylates
CAPSULE;ORAL018706-001Jan 18, 1983► Subscribe► Subscribe
Novartis
HYDERGINE
ergoloid mesylates
SOLUTION;ORAL018418-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Fish and Richardson
Merck
Citi
Accenture
Deloitte
UBS
Cantor Fitzgerald
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot